The Novo Nordisk A/S office successful Bagsvaerd, Denmark, connected Wednesday, Nov. 5, 2025.
Nichlas Pollier | Bloomberg | Getty Images
Shares of Novo Nordisk connected Monday fell arsenic overmuch 11% aft the Danish cause pharmaceutical institution said a highly-anticipated proceedings for Alzheimer's illness failed to conscionable its main goal.
The proceedings tested whether semaglutide -- the progressive constituent successful Novo's blockbuster diabetes and value nonaccomplishment drugs Ozempic and Wegovy -- helped dilatory progression for Alzheimer's disease.
This is breaking news. Please refresh for updates.
English (US) ·